Technology News and Research

RSS

New ISR's report highlights current and future adoption of biomarker technologies

Industry Standard Research (ISR) today announced the release of The State of Biomarkers in Drug Development report. 44 pharmaceutical and biotechnology professionals provided their strategies, insights, and predictions in this snapshot of a rapidly evolving market. In total, 37 significant pharma and biotech companies contributed to this endeavor.

29 Jun 2010

Signature Dx obtains worldwide license to Affymetrix microarray technology for development of CRC tests

Affymetrix, Inc. and Signature Diagnostics AG today announced that they have signed a Powered by Affymetrix™ (PbA) agreement. Under the agreement, Signature Dx obtains a worldwide license to use Affymetrix® microarray technology to develop and commercialize diagnostic and prognostic colorectal cancer (CRC) tests.

29 Jun 2010

LEAPS vaccine technology generates dendritic cells to stimulate immune system to fight viral illnesses

CEL-SCI Corporation and researchers at the Northeastern Ohio Universities Colleges of Medicine and Pharmacy (NEOUCOM) jointly announced today that a LEAPS-based vaccine (Ligand Epitope Antigen Presentation System) study has demonstrated the technology's potential using dendritic cells to stimulate the immune system to fight viral illnesses and other diseases.

29 Jun 2010

Image-guided percutaneous biopsies on the rise

Advanced imaging technologies have helped shift biopsy techniques away from more invasive approaches toward imaging-guided percutaneous-or through the skin-techniques, according to a new study appearing online and in the September print edition of the journal Radiology.

29 Jun 2010

Researchers study mechanism of human brain

Because of its intricate organization, figuring out the wiring diagram that explains how the billions of neurons in the brain are connected, and determining how they work together, remains a formidable task.

29 Jun 2010

Rare human antibodies protect mice from lethal strains of influenza

Scientists have identified a new, highly conserved molecular target on the influenza A virus and demonstrated that human antibodies against this target are protective in animal models of seasonal and highly-pathogenic avian influenza. The work was conducted by researchers at Theraclone Sciences, with collaborators at University of Wisconsin-Madison, University of Tokyo and Johns Hopkins University; and is reported this week in the online Early Edition of the Proceedings of the National Academy of Sciences.

29 Jun 2010

St. Jude Children's Research Hospital ranked among top 10 "Best Places to Work in Academia"

St. Jude Children's Research Hospital is ranked as one of the top institutions in the annual "Best Places to Work in Academia" list by The Scientist magazine. This is the fifth consecutive year St. Jude made the publication's top 10 list of institutions in the United States. The hospital ranks second in the country behind Princeton University.

29 Jun 2010

Scancell, immatics collaborate to develop ImmunoBody vaccines for colorectal cancer

Scancell Holdings Plc,, the developer of therapeutic cancer vaccines, today announces a research collaboration with immatics biotechnologies GmbH to explore the development of novel ImmunoBody® vaccines for colorectal cancer.

29 Jun 2010

Response Biomedical signs subscription agreement for C$8 million private placement

Response Biomedical Corporation announced today the signing of a subscription agreement providing for the sale of C$8 million of its common shares to funds affiliated with OrbiMed Advisors, LLC. The closing of the private placement is subject to receipt of all necessary regulatory approvals, including the approval of the Toronto Stock Exchange and the shareholders of the Company.

29 Jun 2010

International symposium to highlight current and future applications of MR-guided ultrasound

Leading research and clinical experts from around the world are scheduled to speak at the 2nd International Symposium for MR-guided Focused Ultrasound, which will be held October 17 to 20 in the Washington, D.C. area.

From Elekta 29 Jun 2010

New research project to develop reliable and cost-effective virtual autopsies

A new research project at the University of Leicester is set to play a vital role in continuing research into viable alternatives to invasive autopsies, which many families find to be unpleasant.

29 Jun 2010

BioAlliance Pharma presents abstracts on Loramyc, clonidine Lauriad at MASCC/ISOO 2010 symposium

BioAlliance Pharma SA, a company dedicated to the supportive care and treatment of cancer patients, has presented 2 abstracts on Loramyc® and clonidine Lauriad® at the MASCC/ISOO 2010 International Symposium (Vancouver, June 24-26, 2010). These two products belong to the supportive care pipeline of BioAlliance Pharma.

29 Jun 2010

Shrink Nanotechnologies, Lydall enter technology integration and development agreement

Shrink Nanotechnologies, Inc., an innovative nanotechnology company developing products and licensing opportunities in the solar energy production, medical diagnostics and sensors, and biotechnology research and development tools businesses, announced today that it has entered into a technology integration and development agreement with Lydall, Inc..

29 Jun 2010

Movable sequences of DNA are more common than previously thought

Researchers at the University of Leicester have demonstrated that movable sequences of DNA, which give rise to genetic variability and sometimes cause specific diseases, are far more common than previously thought.

29 Jun 2010

A&A journal achieves significant increase in Impact Factor; reflects scientific value of medical journals

Anesthesia & Analgesia (A&A), official journal of the International Anesthesia Research Society (IARS), has achieved a significant increase in its Impact Factor, a key indicator of the influence and scientific value of medical journals, the IARS announced today.

29 Jun 2010

New brain-to-computer chip technology revolutionizes neurological therapy

By stimulating certain areas of the brain, scientists can alleviate the effects of disorders such as depression or Parkinson's disease. That's the good news. But because controlling that stimulation currently lacks precision, over-stimulation is a serious concern - losing some of its therapeutic benefits for the patient over time.

29 Jun 2010

Othello Community Hospital second in nation to achieve Stage 6 on EMR Adoption Model

Othello Community Hospital, an Inland Northwest Health Services (INHS)-networked facility, has been recognized by the Healthcare Information and Management Systems Society (HIMSS) Analytics as achieving Stage 6 on the EMR Adoption Modelsm (EMRAM). Othello is only the second critical access hospital in the nation to receive this distinction, a testament to its commitment to using technology to best serve patients.

28 Jun 2010

Greenway to provide physician's infrastructure solutions to St. Cloud Medical Group

Greenway Medical Technologies, Inc. is partnering with St. Cloud Medical Group to provide its single-database electronic health record (EHR), practice management and interoperability solution PrimeSuite®, online portal PrimePatient® and remote clinic PrimeMobile™ to St. Cloud's primary care, urgent care, occupational health, surgical, pediatrics, pain management, and OB/GYN services.

28 Jun 2010

World's leading pharma services industry events to held at Frankfurt in 2011

Leading events organiser UBM International Media today announced that its flagship CPhI Worldwide tradeshow will return to Frankfurt, Germany for 2011. Along with co-hosted events - P-MEC Europe for equipment, machinery and technology; ICSE for contract services and packaging; and BioPh Europe for the biopharma sector - the world's leading pharma services industry events will be held at Messe Frankfurt, from Tuesday 25 to Thursday 27 October.

28 Jun 2010

Health Canada approves Solta Medical's Thermage CPT, Fraxel re:store Dual systems

Solta Medical, Inc., the pioneer in fractional resurfacing and non-invasive skin tightening and a market leader in aesthetic skin treatments, today announced Health Canada approval of its Thermage CPT™ and Fraxel re:store® Dual systems. These products are now available to physicians in Canada. In the fall of 2009, the company received U.S. FDA clearance to market and sell both the Thermage CPT and Fraxel re:store Dual systems. Both systems are now available in over 100 countries worldwide.

28 Jun 2010

Technology News and Research

New ISR's report highlights current and future adoption of biomarker technologies

Signature Dx obtains worldwide license to Affymetrix microarray technology for development of CRC tests

LEAPS vaccine technology generates dendritic cells to stimulate immune system to fight viral illnesses

Image-guided percutaneous biopsies on the rise

Researchers study mechanism of human brain

Rare human antibodies protect mice from lethal strains of influenza

St. Jude Children's Research Hospital ranked among top 10 "Best Places to Work in Academia"

Scancell, immatics collaborate to develop ImmunoBody vaccines for colorectal cancer

Response Biomedical signs subscription agreement for C$8 million private placement

International symposium to highlight current and future applications of MR-guided ultrasound

New research project to develop reliable and cost-effective virtual autopsies

BioAlliance Pharma presents abstracts on Loramyc, clonidine Lauriad at MASCC/ISOO 2010 symposium

Shrink Nanotechnologies, Lydall enter technology integration and development agreement

Movable sequences of DNA are more common than previously thought

A&A journal achieves significant increase in Impact Factor; reflects scientific value of medical journals

New brain-to-computer chip technology revolutionizes neurological therapy

Othello Community Hospital second in nation to achieve Stage 6 on EMR Adoption Model

Greenway to provide physician's infrastructure solutions to St. Cloud Medical Group

World's leading pharma services industry events to held at Frankfurt in 2011

Health Canada approves Solta Medical's Thermage CPT, Fraxel re:store Dual systems

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News